Induction of Protective CTL Responses Against the Plasmodium yoelii Circumsporozoite Protein by Immunization with Peptides

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3424-3433

  Franke, Eileen D ^a,c   Corradin, Giampietro ^b   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c PSC 452 Box 115 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIELAIDOYLPHOSPHATIDYLETHANOLAMINE; 1,2-DIELAIDOYLPHOSPHATIDYLETHANOLAMINE; CD8 ANTIGEN; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; EPITOPE; IMMUNOLOGICAL ADJUVANT; LIPOSOME; PARASITE ANTIGEN; PEPTIDE FRAGMENT; PHOSPHATIDYLETHANOLAMINE; PROTOZOAL PROTEIN; TETANUS TOXIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CHEMISTRY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HELPER CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALARIA; MOLECULAR GENETICS; MOUSE; PARASITOLOGY; PLASMODIUM YOELII; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD8; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITOPES, T-LYMPHOCYTE; INJECTIONS, SUBCUTANEOUS; LIPOSOMES; LYMPHOCYTE ACTIVATION; MALARIA; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHATIDYLETHANOLAMINES; PLASMODIUM YOELII; PROTOZOAN PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TETANUS TOXIN; VACCINATION;

EID: 0031255317     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Nussenzweig, R. S., J. Vanderberg, H. Most, and C. Orton. 1967. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216:160.
2. Clyde, D. F., V. C. McCarthy, R. M. Miller, and R. B. Hornick. 1973. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266:398.
3. Clyde, D. F., H. Most, V. C. McCarthy, and J. P. Vanderberg. 1973. Immunization of man against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266:169.
4. Clyde, D. F., V. C. McCarthy, R. M. Miller, and W. E. Woodward. 1975. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 24:397.
5. Rieckmann, K. H., P. E. Carson, R. L. Beaudoin, J. S. Cassells, and K. W. Sell. 1974. Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 68:258.
6. Rieckmann, K. H., R. L. Beaudoin, J. S. Cassells, and D. W. Sell. 1979. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull. W. H. O. 57(Suppl. 1):261.
7. Egan, J. E., J. L. Weber, W. R. Ballou, M. R. Hollingdale, W. R. Majarian, D. M. Gordon, W. L. Maloy, S. L. Hoffman, R. A. Wirtz, I. Schneider, O. R. Woollett, J. F. Young, and W. T. Hockmeyer. 1987. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 236:453.
8. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664.
9. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85:573.
10. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3:579.
11. Weiss, W. R., J. A. Berzovsky, R. Houghten, M. Sedegah, M. Hollingdale, and S. L. Hoffman. 1992. A T cell clone directed at the circumsporozoite protein which protects mice against both P. yoelii and P. berghei. J. Immunol. 149:2103.
12. Weiss, W. R., S. Mellouk, R. A. Houghten, M. Sedegah, S. Kumar, M. F. Good, J. A. Berzofsky, L. H. Miller, and S. L. Hoffman. 1990. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 171:763.
13. Khusmith, S., Y. Charoenvit, S. Kumar, M. Sedegah, R. L. Beaudoin, and S. L. Hoffman. 1991. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252:715.
14. + T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA 90:5214.
15. + T and B cell epitopes: comparison of their immunogenicity and capacity to induce protective immunity. J. Immunol. 153:4636.
16. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866.
17. + T-cell protective immunity induced by immunization with Plasmodium berghei CS protein-derived synthetic peptides: evidence that localization of peptide-specific CTLs is crucial for protection against malaria. Immunol. Lett. 46:199.
18. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
19. + cytotoxic T-cell responses? A paradox revisited. Immunol. Today 14:344.
20. Carbone, F. R., and M. J. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169:603.
21. Ishioka, G. Y., S. Colon, C. Miles, H. M. Grey, and R. W. Chesnut. 1989. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo. J. Immunol. 143:1094.
22. Deres, K., H. Schild, K. H. Wiesmuller, G. Jung, and H. G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561.
23. Schild, H., K. Deres, K. H. Wiesmuller, G. Jung, and H. G. Rammensee. 1991. Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. Ear. J. Immunol. 21:2649.
24. Aichele, P., H. Hengartner, R. M. Zinkernagel, and M. Schulz. 1990. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 171:1815.
25. Schulz, M., R. M. Zinkernagel, and H. Hengartner. 1991. Peptide-induced antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 88:991.
26. Kast, W. M., L. Roux, J. Curren, H. J. Blom, A. C. Voordouw, R. H. Meloen, D. Kolakofsky, and C. J. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283.
27. Gao, X. M., B. Zheng, F. Y. Liew, S. Brett, and J. Tite. 1991. Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides. J. Immunol. 147:3268.
28. Zhou, X., L. Berg, U. M. Motal, and M. Jondal. 1992. In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. J Immunol. Methods 153:193.
29. Widmann, C., P. Romero, J. L. Maryanski, G. Corradin, and D. Valmori. 1992. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. J. Immunol. Methods 155:95.
30. + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med. 175:1531.
31. + cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 151: 5096.
32. Scalzo, A. A., S. L. Elliott, J. Cox, J. Gardner, D. J. Moss, and A. Suhrbier. 1995. Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). J. Virol. 69:1306
33. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
34. d-restricted antigenic peptides share a simple binding motif. J. Exp. Med. 174:603.
35. + cells and malaria sporozoites. Immunol. Lett. 25:59.
36. + T lymphocytes from mice immunized with a synthetic malaria peptide. Proc. Natl. Acad. Sci. USA 88:7963.
37. Romero, P. J., J. P. Tam, D. Schlesinger, P. Clavijo, H. Gibson, P. J. Barr, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala. 1988. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei. Eur. J. Immunol. 18:1951.
38. Migliorini, P., B. Betschart, and G. Corradin. 1993. Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity. Eur. J. Immunol. 23:582.
39. Walker, C., M. Selby, A. Erickson, D. Cataldo, J. P. Valensi, and G. Van Nest. 1992. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Proc. Natl. Acad. Sci. USA 89: 7915.
40. Wizel, B., W. O. Rogers, R. A. Houghten, D. E. Lanar, J. A. Tine, and S. L. Hoffman. 1994. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2. Eur. J. Immunol. 24:1487.
41. Panina Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237.
42. Demotz, S., A. Lanzavecchia, U. Eisel, H. Niemann, C. Widmann, and G. Corradin. 1989. Delineation of several DR-retricted tetanus toxin T cell epitopes. J. Immunol. 142:394.
43. Valmori, D., J. F. Romero, Y. Men, J. L. Maryanski, P. Romero, and G. Corradin. 1994. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Eur. J. Immunol. 24: 1458.
44. + CTL in vivo with peptide vaccine constructs. J. Immunol. 152:549.
45. Shirai, M., M. Chen, T. Arichi, T. Masaki, M. Nishioka, M. Newman, T. Nakazawa, S. M. Feinstone, and J. A. Berzofsky. 1996. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines. J. Infect. Dis. 173:24.
46. Vitiello, A., G. Ishioka, H. M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, F. V. Chisari, J. Furze, R. Bartholomeuz, and R. W. Chesnut. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:341.
47. Tam, J. P., P. Clavijo, Y. Lu, V. Nussenzweig, R. Nussenzweig, and F. Zavala. 1990. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 171:299.
48. Munesinghe, D. Y., P. Clavijo, M. C. Calle, R. S. Nussenzweig, and E. Nardin. 1991. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein. Eur. J. Immunol. 21:3015.
49. Chai, S. K., P. Clavijo, J. P. Tam, and F. Zavala. 1992. Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes. J. Immunol. 149:2385.
50. Wang, R., Y. Charoenvit, G. Corradin, R. Porrozzi, R. L. Hunter, G. Glenn, C. R. Alving, P. Church, and S. L. Hoffman. 1995. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J. Immunol. 154:2784.
51. Pessi, A., D. Valmori, P. Migliorini, C. Tougne, E. Bianchi, P. H. Lambert, G. Corradin, and G. Del Giudice. 1991. Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide. Eur. J. Immunol. 21:2273.